Cocrystal Pharma, Inc. — Director's Dealing 2016

Sep 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2016-09-01

Reporting Person: Schinazi Raymond F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-01	Common Stock	P	4878050	$0.41	Acquired	4878050	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	275520853	Direct